LifeStance Health Group, Inc. (LFST) fair value analysis
Nasdaq · Updated 2026-09-07
LifeStance Health Group, Inc. is a healthcare company that provides behavioral health services, including psychiatry, therapy, and other mental health treatments through a combination of in-person and telehealth delivery methods. The company operates across multiple states in the United States, serving patients through its network of clinicians and treatment centers.
Valuation status
Awaiting full valuationLFST does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under our standards — we require at least six validated trailing price-to-earnings windows before publishing one. TickrTrends re-evaluates every covered stock weekly; a verdict publishes automatically once enough validated history accumulates.
- Last price
- $10.54
- Sector
- Healthcare
- 12-month range
- $4.92–$11.43
Derived indicators
Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.
- Quality grade
- D
- Momentum grade
- A
- Leverage
- Low
- RSI zone
- Overbought
- 50/200-day trend
- Mixed
- 52-week position
- The top quarter of its range
What our data shows for LFST
- Our model validated 5 trailing price-to-earnings windows for LFST, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $4.92–$11.43.
- The 14-day relative strength index sits at an overbought 71.
- 3 of the last 12 weekly snapshots showed positive price momentum.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for LFST
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.
Recent LFST news
TickrTrends' derived news-sentiment signal for LFST is currently mixed, computed from recent coverage.
- LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue? (zacks.com, 2026-09-03)
TickrTrends take: LFST has reached its 52 week high, marking a significant movement in its stock price that warrants examination alongside its fundamental metrics. Since TickrTrends is currently awaiting full valuation data for this Healthcare sector company, investors tracking the stock's valuation should monitor whether the recent price strength reflects sustainable improvements in the company's underlying business metrics or represents a temporary momentum move. The completion of a comprehensive valuation analysis would provide essential context for determining whether current price levels are supported by the company's financial fundamentals. - LifeStance to Present at Upcoming Investor Conferences (manilatimes.net, 2026-09-01)
TickrTrends take: LifeStance's upcoming investor conference presentations provide an opportunity for the market to assess the company's strategic direction and financial performance, which will inform how analysts approach valuation in the Healthcare sector. Since TickrTrends currently shows an awaiting full valuation status for LFST, these presentations may supply the operational metrics and guidance needed to establish a more complete valuation picture. Investors focused on valuation should monitor what management emphasizes regarding growth trajectory, profitability path, and capital efficiency during these events. - LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know (zacks.com, 2026-08-13)
TickrTrends take: LifeStance Health Group's recent weekly gain occurs while TickrTrends maintains an awaiting full valuation status for the stock, meaning a comprehensive valuation assessment is still pending. For investors focused on valuation metrics, this price movement highlights the importance of waiting for complete fundamental analysis before drawing conclusions about the company's value relative to its Healthcare sector peers. The stock's near-term performance should be monitored alongside upcoming valuation data that could provide clarity on whether current price levels represent attractive entry points or require reassessment.
What people are saying
Follow the LFST conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-06 — TickrTrends' derived indicators for LFST showed notable movement this week. Momentum upgraded from none to A, while the relative strength index zone shifted from neutral to overbought. The stock's current valuation verdict remains awaiting full valuation.
- 2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is LFST stock undervalued?
LFST does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under TickrTrends' standards; it is re-evaluated every week.
What is LFST's TickrTrends verdict?
LFST is currently marked 'Awaiting full valuation' - a verdict publishes automatically once at least six validated trailing P/E windows accumulate.
Is LFST overbought or oversold?
LFST's 14-day RSI is in the overbought zone on TickrTrends' latest weekly data.